Prelude Therapeutics (PRLD) will price its IPO of 8.325M common shares between $17 – 19 per share yielding ~$150M at the midpoint.
https://seekingalpha.com/news/3615705-prelude-therapeutics-sets-terms-of-150m-ipo
Prelude Therapeutics (PRLD) will price its IPO of 8.325M common shares between $17 – 19 per share yielding ~$150M at the midpoint.
https://seekingalpha.com/news/3615705-prelude-therapeutics-sets-terms-of-150m-ipo
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.